Scholars Central

Short communicationPublished 2020

Supramolecular theranostics goes green

Authors: Esra Demirdogen, Fatih Mehmet EMEN

Acta Chimica and Pharmaceutica Indica

Volume 10 · Issue 2 · Pages 29

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Unsustainable life, production and consumption styles focusing on quantity and often overlooking other goals have brought environment and public health to the breaking point of today and caused many different diseases to appear while increasing incidence and prevalence of all diseases among which cancer is of major concern. World Health Organization projected the number of deaths due to cancer alone to be ~13.1 million by 2030. To a certain extent conventional chemotherapy has been successful, but poor bioavailability, high-dose requirements, adverse side effects, low therapeutic indices, development of multiple drug resistance, and non-specific targeting have been severe limitations to its success. These limitations can be overcome via “theranostics” as it is precision medicine providing simultaneous diagnosis, targeted treatment and monitoring. Here the major actor is the drug – the therapeutic compound. Conventional applications suffer from limited effectiveness, poor bio distribution, and lack of selectivity, but developing new drug molecule is expensive and time consuming. Therefore, for to improve the safety efficacy ratio of “old” drugs by individualizing drug therapy, dose titration, and therapeutic drug monitoring nanotechnology and green chemistry provided the required formulations, which have optimal pharmacokinetic properties for in vivo applications, since their Nano size allowed them to be subject to tissue extravasations and renal clearance whereas their counterparts are quickly opsonized and removed from the bloodstream via the macrophages. Therefore, it is of great need and importance to develop new green chemistries and technologies to produce supramolecular Nano medicines by employing appropriate inorganic and organic structures as theranostic platforms. This talk will be about development and production of smart theranostic systems with high biocompatibility, loading efficiency, circulation stability, predetermined release kinetics, targeting and monitoring of anti-tumor agents via a new green production technique: electrohydrodynamic atomization modified by pressurized green solvents. A new light switchable/controllable delivery system composed of mesoporous composite materials such as MMoO4: Eu- MCM-41-Fe2O3 capable of magnetic and luminescent properties and controlled drug release will be introduced

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Acta Chimica and Pharmaceutica Indica.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalActa Chimica and Pharmaceutica Indica
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Esra Demirdogen”
  • BylineArticles whose byline prints “Fatih Mehmet EMEN”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels